Pennati M - Search Results

1

Approaches for the inhibition of human telomerase based on the use of peptide nucleic acids and hammerhead ribozymes.

Zaffaroni N, Villa R, Pennati M, Folini M. Zaffaroni N, et al. Among authors: pennati m. Mini Rev Med Chem. 2003 Feb;3(1):51-60. doi: 10.2174/1389557033405458. Mini Rev Med Chem. 2003. PMID: 12570854 Review.

2

Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells.

Villa R, Folini M, Porta CD, Valentini A, Pennati M, Daidone MG, Zaffaroni N. Villa R, et al. Among authors: pennati m. Carcinogenesis. 2003 May;24(5):851-9. doi: 10.1093/carcin/bgg028. Carcinogenesis. 2003. PMID: 12771028

3

Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs.

Zaffaroni N, Pennati M, Folini M. Zaffaroni N, et al. Among authors: pennati m. Methods Mol Biol. 2007;361:239-63. doi: 10.1385/1-59745-208-4:239. Methods Mol Biol. 2007. PMID: 17172716 Review.

4

Targeting human telomerase by antisense oligonucleotides and ribozymes.

Folini M, Pennati M, Zaffaroni N. Folini M, et al. Among authors: pennati m. Curr Med Chem Anticancer Agents. 2002 Sep;2(5):605-12. doi: 10.2174/1568011023353813. Curr Med Chem Anticancer Agents. 2002. PMID: 12678727 Review.

5

Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression.

Pennati M, Binda M, Colella G, Folini M, Citti L, Villa R, Daidone MG, Zaffaroni N. Pennati M, et al. J Invest Dermatol. 2003 Apr;120(4):648-54. doi: 10.1046/j.1523-1747.2003.12082.x. J Invest Dermatol. 2003. PMID: 12648230 Free article.

6

Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.

Pennati M, Binda M, Colella G, Zoppe' M, Folini M, Vignati S, Valentini A, Citti L, De Cesare M, Pratesi G, Giacca M, Daidone MG, Zaffaroni N. Pennati M, et al. Oncogene. 2004 Jan 15;23(2):386-94. doi: 10.1038/sj.onc.1207071. Oncogene. 2004. PMID: 14724567

7

Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.

Pennati M, Binda M, De Cesare M, Pratesi G, Folini M, Citti L, Daidone MG, Zunino F, Zaffaroni N. Pennati M, et al. Carcinogenesis. 2004 Jul;25(7):1129-36. doi: 10.1093/carcin/bgh107. Epub 2004 Feb 4. Carcinogenesis. 2004. PMID: 14764461

8

Survivin as a target for new anticancer interventions.

Zaffaroni N, Pennati M, Daidone MG. Zaffaroni N, et al. Among authors: pennati m. J Cell Mol Med. 2005 Apr-Jun;9(2):360-72. doi: 10.1111/j.1582-4934.2005.tb00361.x. J Cell Mol Med. 2005. PMID: 15963255 Free PMC article. Review.

9

Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells.

Paduano F, Villa R, Pennati M, Folini M, Binda M, Daidone MG, Zaffaroni N. Paduano F, et al. Among authors: pennati m. Mol Cancer Ther. 2006 Jan;5(1):179-86. doi: 10.1158/1535-7163.MCT-05-0132. Mol Cancer Ther. 2006. PMID: 16432177

10

Small-molecule targeting of heat shock protein 90 chaperone function: rational identification of a new anticancer lead.

Meli M, Pennati M, Curto M, Daidone MG, Plescia J, Toba S, Altieri DC, Zaffaroni N, Colombo G. Meli M, et al. Among authors: pennati m. J Med Chem. 2006 Dec 28;49(26):7721-30. doi: 10.1021/jm060836y. J Med Chem. 2006. PMID: 17181154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters